# Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

> **NCT06539481** · PHASE4 · RECRUITING · sponsor: **Alimera Sciences** · enrollment: 25 (estimated)

## Conditions studied

- Non-infectious Uveitis Affecting the Posterior Segment of the Eye

## Interventions

- **DRUG:** fluocinolone acetonide 190 micrograms

## Key facts

- **NCT ID:** NCT06539481
- **Lead sponsor:** Alimera Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-31
- **Primary completion:** 2026-07-15
- **Final completion:** 2028-10-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06539481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06539481, "Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06539481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*